Active Ingredient(s): Tolazamide
FDA Approved: * July 18, 1966
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tolinase Overview

Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonylurea family (ATC A10BB). Synthesis Tolazemide synthesis:[1] U.S. Patent 3,063,903 GB 887886 DE 1196200 para-Toluenesulfonamide is converted to its carbamate with ethyl chloroformate in the presence of a base. Heating that intermediate with 1-amino-azepane leads to the displacement of the ethoxy group and the formation of tolazemide:[1] Azepane ...

Read more Tolinase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Tolinase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 100mg, 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tolinase: (3 results)

Sorted by National Drug Code
  • 0009-0070 Tolinase 100 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-0114 Tolinase 250 mg Oral Tablet by Pharmacia and Upjohn Company
  • 0009-0477 Tolinase 500 mg Oral Tablet by Pharmacia and Upjohn Company

Other drugs which contain Tolazamide or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA